
Ross N Gushi
Examiner (ID: 15280)
Most Active Art Unit | 2833 |
Art Unit(s) | 2832, 2833, 2834 |
Total Applications | 3081 |
Issued Applications | 2594 |
Pending Applications | 110 |
Abandoned Applications | 352 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7491009
[patent_doc_number] => 20110237780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'ANTI-INFLAMMATORY DAB'
[patent_app_type] => utility
[patent_app_number] => 13/008342
[patent_app_country] => US
[patent_app_date] => 2011-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7310
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20110237780.pdf
[firstpage_image] =>[orig_patent_app_number] => 13008342
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/008342 | Anti-inflammatory dAb | Jan 17, 2011 | Issued |
Array
(
[id] => 7586382
[patent_doc_number] => 20110280892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'TOXIN CONJUGATED EPH RECEPTOR ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 12/974953
[patent_app_country] => US
[patent_app_date] => 2010-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 71
[patent_figures_cnt] => 71
[patent_no_of_words] => 64907
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20110280892.pdf
[firstpage_image] =>[orig_patent_app_number] => 12974953
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/974953 | TOXIN CONJUGATED EPH RECEPTOR ANTIBODIES | Dec 20, 2010 | Abandoned |
Array
(
[id] => 8347793
[patent_doc_number] => 20120208718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-16
[patent_title] => 'SCHIZOPHRENIA TREATMENT RESPONSE BIOMARKERS'
[patent_app_type] => utility
[patent_app_number] => 13/499672
[patent_app_country] => US
[patent_app_date] => 2010-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10918
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13499672
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/499672 | SCHIZOPHRENIA TREATMENT RESPONSE BIOMARKERS | Sep 30, 2010 | Abandoned |
Array
(
[id] => 6202399
[patent_doc_number] => 20110065185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'MUTATED ANTI-CD22 ANTIBODIES WITH INCREASED AFFINITY TO CD22-EXPRESSING LEUKEMIA CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/846625
[patent_app_country] => US
[patent_app_date] => 2010-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19514
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20110065185.pdf
[firstpage_image] =>[orig_patent_app_number] => 12846625
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/846625 | MUTATED ANTI-CD22 ANTIBODIES WITH INCREASED AFFINITY TO CD22-EXPRESSING LEUKEMIA CELLS | Jul 28, 2010 | Abandoned |
Array
(
[id] => 6268336
[patent_doc_number] => 20100298544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'CDR-GRAFTED ANTI-TISSUE FACTOR ANTIBODIES AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/797737
[patent_app_country] => US
[patent_app_date] => 2010-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 12792
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12797737
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/797737 | CDR-GRAFTED ANTI-TISSUE FACTOR ANTIBODIES AND METHODS OF USE THEREOF | Jun 9, 2010 | Abandoned |
Array
(
[id] => 8571928
[patent_doc_number] => 08338576
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-25
[patent_title] => 'Antibodies specific for DKK-1 and their uses'
[patent_app_type] => utility
[patent_app_number] => 12/777806
[patent_app_country] => US
[patent_app_date] => 2010-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 24
[patent_no_of_words] => 56498
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12777806
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/777806 | Antibodies specific for DKK-1 and their uses | May 10, 2010 | Issued |
Array
(
[id] => 6326876
[patent_doc_number] => 20100197595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'TREATMENT OF MELANOMA WITH ALPHA THYMOSIN PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/758714
[patent_app_country] => US
[patent_app_date] => 2010-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4787
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20100197595.pdf
[firstpage_image] =>[orig_patent_app_number] => 12758714
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/758714 | TREATMENT OF MELANOMA WITH ALPHA THYMOSIN PEPTIDES | Apr 11, 2010 | Abandoned |
Array
(
[id] => 4596491
[patent_doc_number] => 07982024
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-19
[patent_title] => 'Antibodies to insulin-like growth factor I receptor'
[patent_app_type] => utility
[patent_app_number] => 12/756417
[patent_app_country] => US
[patent_app_date] => 2010-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 29
[patent_no_of_words] => 36375
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/982/07982024.pdf
[firstpage_image] =>[orig_patent_app_number] => 12756417
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/756417 | Antibodies to insulin-like growth factor I receptor | Apr 7, 2010 | Issued |
Array
(
[id] => 6340053
[patent_doc_number] => 20100247545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'ANTIBODIES TO M-CSF'
[patent_app_type] => utility
[patent_app_number] => 12/748602
[patent_app_country] => US
[patent_app_date] => 2010-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 37472
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20100247545.pdf
[firstpage_image] =>[orig_patent_app_number] => 12748602
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/748602 | Nucleic acid molecules encoding antibodies to M-CSF | Mar 28, 2010 | Issued |
Array
(
[id] => 6503979
[patent_doc_number] => 20100260752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'OPSONIC AND PROTECTIVE ANTIBODIES SPECIFIC FOR LIPOTEICHOIC ACID OF GRAM POSITIVE BACTERIA'
[patent_app_type] => utility
[patent_app_number] => 12/691908
[patent_app_country] => US
[patent_app_date] => 2010-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 35471
[patent_no_of_claims] => 102
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20100260752.pdf
[firstpage_image] =>[orig_patent_app_number] => 12691908
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/691908 | OPSONIC AND PROTECTIVE ANTIBODIES SPECIFIC FOR LIPOTEICHOIC ACID OF GRAM POSITIVE BACTERIA | Jan 21, 2010 | Abandoned |
Array
(
[id] => 8629396
[patent_doc_number] => 08361465
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-29
[patent_title] => 'Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents'
[patent_app_type] => utility
[patent_app_number] => 12/690033
[patent_app_country] => US
[patent_app_date] => 2010-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 37117
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 298
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12690033
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/690033 | Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents | Jan 18, 2010 | Issued |
Array
(
[id] => 6633191
[patent_doc_number] => 20100173428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'Protein Phosphorylation By Basophillic Serine/Threonine Kinases'
[patent_app_type] => utility
[patent_app_number] => 12/683835
[patent_app_country] => US
[patent_app_date] => 2010-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 32017
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20100173428.pdf
[firstpage_image] =>[orig_patent_app_number] => 12683835
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/683835 | Protein Phosphorylation By Basophillic Serine/Threonine Kinases | Jan 6, 2010 | Abandoned |
Array
(
[id] => 6560246
[patent_doc_number] => 20100272640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-28
[patent_title] => 'Monoclonal Antibodies Against PCBP-1 Antigens, and Uses Therefor'
[patent_app_type] => utility
[patent_app_number] => 12/684090
[patent_app_country] => US
[patent_app_date] => 2010-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 16344
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20100272640.pdf
[firstpage_image] =>[orig_patent_app_number] => 12684090
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/684090 | Monoclonal Antibodies Against PCBP-1 Antigens, and Uses Therefor | Jan 6, 2010 | Abandoned |
Array
(
[id] => 6453268
[patent_doc_number] => 20100189649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-29
[patent_title] => 'MONOCLONAL ANTIBODIES TO ACTIVATED ERBB FAMILY MEMBERS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/651527
[patent_app_country] => US
[patent_app_date] => 2010-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 27874
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20100189649.pdf
[firstpage_image] =>[orig_patent_app_number] => 12651527
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/651527 | MONOCLONAL ANTIBODIES TO ACTIVATED ERBB FAMILY MEMBERS AND METHODS OF USE | Jan 3, 2010 | Abandoned |
Array
(
[id] => 7510806
[patent_doc_number] => 20110256579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'Method for Verifying and/or Identifying Hormonally Effective Substances'
[patent_app_type] => utility
[patent_app_number] => 13/141342
[patent_app_country] => US
[patent_app_date] => 2009-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15619
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20110256579.pdf
[firstpage_image] =>[orig_patent_app_number] => 13141342
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/141342 | Method for Verifying and/or Identifying Hormonally Effective Substances | Dec 21, 2009 | Abandoned |
Array
(
[id] => 6581864
[patent_doc_number] => 20100291111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'Use of Anti-Alpha5Beta1 Antibodies to Inhibit Cancer Cell Proliferation'
[patent_app_type] => utility
[patent_app_number] => 12/642687
[patent_app_country] => US
[patent_app_date] => 2009-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16696
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20100291111.pdf
[firstpage_image] =>[orig_patent_app_number] => 12642687
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/642687 | Use of Anti-Alpha5Beta1 Antibodies to Inhibit Cancer Cell Proliferation | Dec 17, 2009 | Abandoned |
Array
(
[id] => 8214620
[patent_doc_number] => 08193316
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-05
[patent_title] => 'TACI-Fc fusion proteins, methods of making and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/638392
[patent_app_country] => US
[patent_app_date] => 2009-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10207
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/193/08193316.pdf
[firstpage_image] =>[orig_patent_app_number] => 12638392
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/638392 | TACI-Fc fusion proteins, methods of making and uses thereof | Dec 14, 2009 | Issued |
61/275723 | ANTI-INFLAMMATORY ANTIBODIES AND USES THEREFOR | Dec 6, 2009 | Pending |
Array
(
[id] => 6635067
[patent_doc_number] => 20100226854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-09
[patent_title] => 'MHC Peptide Complexes and Uses Thereof in Infectious Diseases'
[patent_app_type] => utility
[patent_app_number] => 12/619039
[patent_app_country] => US
[patent_app_date] => 2009-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 77
[patent_figures_cnt] => 77
[patent_no_of_words] => 225802
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20100226854.pdf
[firstpage_image] =>[orig_patent_app_number] => 12619039
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/619039 | MHC peptide complexes and uses thereof in infectious diseases | Nov 15, 2009 | Issued |
Array
(
[id] => 7685454
[patent_doc_number] => 20100120687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'Modulating apoptosis'
[patent_app_type] => utility
[patent_app_number] => 12/617639
[patent_app_country] => US
[patent_app_date] => 2009-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 17113
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20100120687.pdf
[firstpage_image] =>[orig_patent_app_number] => 12617639
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/617639 | Modulating apoptosis | Nov 11, 2009 | Issued |